Literature DB >> 16094770

Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment.

Vincent Cogliano, Yann Grosse, Robert Baan, Kurt Straif, Béatrice Secretan, Fatiha El Ghissassi.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16094770     DOI： 10.1016/s1470-2045(05)70273-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  38 in total

1.  The contraceptive revolution: some excellent progress but work still to be done.

Authors:  Philip Hannaford; Toni Belfield
Journal:  Br J Gen Pract       Date:  2009-01       Impact factor: 5.386

2.  Breast Cancer Risk Factors among Ugandan Women at a Tertiary Hospital: A Case-Control Study.

Authors:  Moses Galukande; Henry Wabinga; Florence Mirembe; Charles Karamagi; Alexzander Asea
Journal:  Oncology       Date:  2016-04-23       Impact factor: 2.935

3.  Molecular screening of Chinese medicinal plants for progestogenic and anti-progestogenic activity.

Authors:  H M Manir Ahmed; Jan-Ying Yeh; Yi-Chia Tang; Winston Teng-Kuei Cheng; Bor-Rung Ou
Journal:  J Biosci       Date:  2014-06       Impact factor: 1.826

4.  Human papillomavirus in upper digestive tract tumors from three countries.

Authors:  Andres Castillo; Chihaya Koriyama; Michiyo Higashi; Muhammad Anwar; Mulazim Hussain Bukhari; Edwin Carrascal; Lida Mancilla; Hiroshi Okumura; Masataka Matsumoto; Kazumasa Sugihara; Shoji Natsugoe; Yoshito Eizuru; Suminori Akiba
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

5.  Oral contraceptive use and kidney cancer risk among women: evidence from a meta-analysis.

Authors:  Huan Liu; Xing-Chun Wang; Guang-Hui Hu; Tian-Bao Huang; Yun-Fei Xu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

6.  Circulating Receptor Activator of Nuclear Factor-κB (RANK), RANK ligand (RANKL), and Mammographic Density in Premenopausal Women.

Authors:  Adetunji T Toriola; Catherine M Appleton; Xiaoyu Zong; Jingqin Luo; Katherine Weilbaecher; Rulla M Tamimi; Graham A Colditz
Journal:  Cancer Prev Res (Phila)       Date:  2018-10-23

7.  Decline in hormone replacement prescription and fall in breast cancer incidence: an epidemiological discourse.

Authors:  Andreas Stang
Journal:  Dtsch Arztebl Int       Date:  2008-04-18       Impact factor: 5.594

8.  Oral contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai.

Authors:  Karin A Rosenblatt; Dao L Gao; Roberta M Ray; Zakia C Nelson; Karen J Wernli; Wenjin Li; David B Thomas
Journal:  Cancer Causes Control       Date:  2008-08-15       Impact factor: 2.506

9.  Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy.

Authors:  Li Li; Jia Ji; Jian-Bing Wang; Mayineur Niyazi; You-Lin Qiao; Paolo Boffetta
Journal:  Chin J Cancer Res       Date:  2012-03       Impact factor: 5.087

10.  Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study.

Authors:  Philip C Hannaford; Sivasubramaniam Selvaraj; Alison M Elliott; Valerie Angus; Lisa Iversen; Amanda J Lee
Journal:  BMJ       Date:  2007-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.